BIOMAT Database Logo BIOMAT Database Logo

Radical surgery after neoadjuvant intra-arterial chemotherapy in stage IIIb squamous cell carcinoma of the cervix. 1999

T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume City, Fukuoka, Japan.

We examined the efficacy and safety of neoadjuvant intra-arterial chemotherapy (NAC) followed by radical hysterectomy and/or radiotherapy in patients with stage IIIb cervical cancer. Treatment consisted of bilateral internal iliac artery infusion of cisplatin or carboplatin and peplomycin every 21 days for two courses. Patients who responded to NAC underwent radical surgery. Patients who did not respond to NAC were treated with pelvic radiotherapy. Complete response was achieved in 2 (7.1%) of 28 patients, while a partial response was observed in 17 (60.7%) and stable disease in 9 (32.1%) patients. Sixteen patients (57.2%) were able to undergo surgery. The median blood loss (674 ml) and operating time (232 min) for radical surgery in patients with stage IIIb disease was similar to that in patients with stages Ib to IIb disease. No intra-operative or immediate postoperative complications were observed. The 5-year disease-free survival (DFS) for patients who underwent surgery (81.3%) was higher than for patients who underwent radiotherapy after NAC (31.3%). Radical surgery after NAC for stage IIIb disease was safe, and a survival benefit followed by surgery with or without radiotherapy.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Prognosis of patients with stage IIIb-IVa squamous cell carcinoma of the cervix following intra-arterial neoadjuvant chemotherapy.
June 1999, Journal of experimental & clinical cancer research : CR,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
[Neoadjuvant chemotherapy in locally advanced squamous carcinoma of the uterine cervix (IB2 - IIIB stage)].
January 2002, Akusherstvo i ginekologiia,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
May 1997, Gynecologic oncology,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma.
January 1990, Cancer chemotherapy and pharmacology,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Intra-arterial neoadjuvant chemotherapy followed by radical surgery and radiotherapy for stage IIb cervical carcinoma.
January 1997, Anticancer research,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
October 2009, International journal of radiation oncology, biology, physics,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2.
May 2005, Gynecologic oncology,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer.
September 1998, Annals of surgical oncology,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma.
March 2021, Journal of thoracic disease,
T Sugiyama, and T Nishida, and Y Muraoka, and T Tokuda, and H Kuromatsu, and K Fujiyoshi, and M Yakushiji, and O Edamitu, and N Haynbuchi
Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer.
July 2018, Cancer research and treatment,
Copied contents to your clipboard!